Skip to main content

Published locations for IBD patients more likely to stick with vedolizumab than anti-TNF drugs

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. IBD patients more likely to stick with vedolizumab than anti-TNF drugs

User login

  • Reset your password
  • /content/ibd-patients-more-likely-stick-vedolizumab-anti-tnf-drugs
  • /familypracticenews/article/233892/gastroenterology/ibd-patients-more-likely-stick-vedolizumab-anti
  • /fedprac/article/233892/gastroenterology/ibd-patients-more-likely-stick-vedolizumab-anti-tnf-drugs
  • /gihepnews/article/233892/gastroenterology/ibd-patients-more-likely-stick-vedolizumab-anti-tnf-drugs
  • /internalmedicinenews/article/233892/gastroenterology/ibd-patients-more-likely-stick-vedolizumab-anti
  • /internalmedicine/article/233892/gastroenterology/ibd-patients-more-likely-stick-vedolizumab-anti-tnf
  • /familymedicine/article/233892/gastroenterology/ibd-patients-more-likely-stick-vedolizumab-anti-tnf